Home/Filings/4/0001209191-23-059931
4//SEC Filing

Hants Brandon 4

Accession 0001209191-23-059931

CIK 0001801777other

Filed

Dec 27, 7:00 PM ET

Accepted

Dec 28, 5:31 PM ET

Size

21.0 KB

Accession

0001209191-23-059931

Insider Transaction Report

Form 4
Period: 2023-12-27
Hants Brandon
VP, Finance & Bus. Ops.
Transactions
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2023-12-27150,6720 total
    Exercise: $2.38Exp: 2029-03-26Common Stock (150,672 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2023-12-274,3280 total
    Exercise: $4.61Exp: 2030-03-30Common Stock (4,328 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2023-12-2776,0000 total
    Exercise: $56.61Exp: 2031-03-01Common Stock (76,000 underlying)
  • Disposition to Issuer

    Stock Option (RIght to Buy)

    2023-12-2735,0000 total
    Exercise: $3.99Exp: 2032-05-16Common Stock (35,000 underlying)
  • Disposition to Issuer

    Common Stock

    2023-12-27301,2250 total
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2023-12-2720,0000 total
    Exercise: $14.00Exp: 2030-06-04Common Stock (20,000 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2023-12-2757,4000 total
    Exercise: $8.29Exp: 2032-02-15Common Stock (57,400 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2023-12-2750,0000 total
    Exercise: $0.36Exp: 2033-12-26Common Stock (50,000 underlying)
Footnotes (4)
  • [F1]Pursuant to the Agreement and Plan of Merger dated as of September 21, 2023 (the "Merger Agreement"), by and among Cyclo Therapeutics, Inc. ("Cyclo"), Cameo Merger Sub, Inc. and the Issuer, each share of Issuer's Common Stock was converted into 0.1331 of a share of Cyclo Common Stock (the "Transaction Consideration").
  • [F2]Upon consummation of the Merger, the Reporting Person received Transaction Consideration of 40,094 shares of Cyclo common stock.
  • [F3]Pursuant to the Merger Agreement, at the effective time of the merger, each outstanding option with an exercise price of $0.40 or more was cancelled effective as of the closing.
  • [F4]Pursuant to the Merger Agreement, this option was exchanged for an option covering 6,655 shares of Cyclo Common Stock.

Issuer

Applied Molecular Transport Inc.

CIK 0001801777

Entity typeother

Related Parties

1
  • filerCIK 0001813219

Filing Metadata

Form type
4
Filed
Dec 27, 7:00 PM ET
Accepted
Dec 28, 5:31 PM ET
Size
21.0 KB